Tau protein, the paired helical filament and Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2006-07-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2006-9S323PMID 16914859
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins*

  2005cited by this paper
• Anthraquinones Inhibit Tau Aggregation and Dissolve Alzheimer's Paired Helical Filaments in Vitro and in Cells*

  2005cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-β structure

  2003cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure.

  2000cited by this paper
• Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy

  2000cited by this paper
• Abnormal tau-containing filaments in neurodegenerative diseases.

  2000cited by this paper
• Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

  1999cited by this paper
• Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

  1999cited by this paper
• RNA sequestration to pathological lesions of neurodegenerative diseases

  1998cited by this paper
• Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

  1998cited by this paper
• A nucleated assembly mechanism of Alzheimer paired helical filaments.

  1998cited by this paper
• Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17: A New Group of Tauopathies

  1998cited by this paper
• Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

  1998cited by this paper
• Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau.

  1998cited by this paper
• Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

  1998cited by this paper
• Tau is a candidate gene for chromosome 17 frontotemporal dementia

  1998cited by this paper
• Auguste D and Alzheimer's disease.

  1997cited by this paper
• Genetic evidence for the involvement of τ in progressive supranuclear palsy

  1997cited by this paper
• Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

  1997cited by this paper
• Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

  1997cited by this paper
• Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans

  1997cited by this paper
• MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption.

  1997cited by this paper
• Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

  1997cited by this paper
• Specific Pathological Tau Protein Variants Characterize Pick's Disease

  1996cited by this paper
• Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction

  1996cited by this paper
• Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction.

  1996cited by this paper
• Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

  1996cited by this paper
• Auguste D. and Alzheimer's Disease

  1996cited by this paper
• RNA stimulates aggregation of microtubule‐associated protein tau into Alzheimer‐like paired helical filaments

  1996cited by this paper
• Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles

  1996cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

  1995cited by this paper
• Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*)

  1995cited by this paper
• Candidate gene for the chromosome 1 familial Alzheimer's disease locus

  1995cited by this paper
• Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.

  1994cited by this paper
• Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22.

  1994cited by this paper
• Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

  1994cited by this paper
• PHF‐tau from Alzheimer's brain comprises four species on SDS‐PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase‐3β

  1994cited by this paper
• Evidence of subtypes of Alzheimer's disease and implications for etiology.

  1993cited by this paper
• Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

  1993cited by this paper
• Tau in paired helical filaments is functionally distinct from fetal tau: assembly incompetence of paired helical filament-tau.

  1993cited by this paper
• Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.

  1993cited by this paper
• τ in Paired Helical Filaments Is Functionally Distinct from Fetal τ: Assembly Incompetence of Paired Helical Filament‐τ

  1993cited by this paper
• The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

  1993cited by this paper
• A cdc2‐related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline‐directed protein kinase associated with microtubule

  1993cited by this paper
• Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain.

  1992cited by this paper
• The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease

  1992cited by this paper
• Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

  1992cited by this paper
• Primary structure of high molecular weight tau present in the peripheral nervous system.

  1992cited by this paper
• Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

  1992cited by this paper
• Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.

  1992cited by this paper
• Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tau

  1992cited by this paper
• Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.

  1992cited by this paper
• Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments

  1992cited by this paper
• p42 map kinase phosphorylation sites in microtubule‐associated protein tau are dephosphorylated by protein phosphatase 2A1 Implications for Alzheimer's disease

  1992cited by this paper
• Fetal-type phosphorylation of the tau in paired helical filaments.

  1992cited by this paper
• Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

  1992cited by this paper
• Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro

  1992cited by this paper
• Straight and paired helical filaments in Alzheimer disease have a common structural unit.

  1991cited by this paper
• Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

  1991cited by this paper
• Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer's disease

  1991cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

  1991cited by this paper
• Abnormal Tau proteins in progressive supranuclear palsy

  1991cited by this paper
• Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

  1990cited by this paper
• A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

  1990cited by this paper
• Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.

  1990cited by this paper
• Cloning and sequencing of the cDNA encoding an isoform of microtubule‐associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

  1989cited by this paper
• The microtubule binding domain of tau protein.

  1989cited by this paper
• Two separate 18-amino acid domains of tau promote the polymerization of tubulin.

  1989cited by this paper
• Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

  1989cited by this paper
• Abnormal tau species are produced during Alzheimer's disease neurodegenerating process

  1989cited by this paper
• Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

  1988influential reference
• Structural characterization of the core of the paired helical filament of Alzheimer disease.

  1988influential reference
• The primary structure and heterogeneity of tau protein from mouse brain.

  1988cited by this paper
• The carboxyl third of tau is tightly bound to paired helical filaments.

  1988cited by this paper
• Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

  1988cited by this paper
• Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.

  1987cited by this paper
• Ubiquitin is a component of paired helical filaments in Alzheimer's disease.

  1987cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein? (tau) in Alzheimer cytoskeletal pathology

  1987cited by this paper
• Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.

  1987cited by this paper
• Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles.

  1987cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• A neuronal antigen in the brains of Alzheimer patients.

  1986cited by this paper
• Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments

  1986cited by this paper
• One of the antigenic determinants of paired helical filaments is related to tau protein.

  1986cited by this paper
• Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

  1986cited by this paper
• Alzheimer's paired helical filaments share epitopes with neurofilament side arms.

  1986cited by this paper
• Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease.

  1986cited by this paper
• Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease.

  1986cited by this paper
• Identification of cDNA clones for the human microtubule-associated protein tau and chromosomal localization of the genes for tau and microtubule-associated protein 2.

  1986cited by this paper
• Paired helical filaments associated with Alzheimer disease are readily soluble structures.

  1986cited by this paper
• Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)

  1986cited by this paper
• Mise en évidence immunologique de la protéine tau au niveau des lésions de dégénérescence neurofibrillaire de la maladie d'Alzheimer

  1985cited by this paper
• Image reconstruction of the Alzheimer paired helical filament.

  1985cited by this paper
• Subunit structure of paired helical filaments in Alzheimer's disease

  1985cited by this paper
• Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

  1985cited by this paper
• Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles.

  1984cited by this paper

• Discovery of Selective β-Secretase (BACE-1) Inhibitors by the Solid-Phase Synthesis of Small Molecular-sized Peptides.

  2025cites this paper
• Targeting mitochondrial dysfunction in Alzheimer's disease: New findings and perspectives.

  2025cites this paper
• Umbrella Refinement of Ensembles—An Alternative View of Ensemble Optimization

  2025cites this paper
• Roles of 4′-O-Methylalpinum Isoflavone on Activation of Microglia Induced by Oxysterols

  2024cites this paper
• The co-oligomers of Aβ42 and human islet amyloid polypeptide exacerbate neurotoxicity and Alzheimer-like pathology at cellular level.

  2024cites this paper
• Oxidative Processes and Xenobiotic Metabolism in Plants: Mechanisms of Defense and Potential Therapeutic Implications

  2024cites this paper
• Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates.

  2024cites this paper
• Conformational dependence of chemical shifts in the proline rich region of TAU protein

  2024cites this paper
• Fetal alcohol exposure impairs learning and memory functions and elevates levels of various biochemical markers of Alzheimer's disease in the brain of twelve-month-old rats.

  2023cites this paper
• Complicated Role of Post-translational Modification and Protease-Cleaved Fragments of Tau in Alzheimer’s Disease and Other Tauopathies

  2023cites this paper
• Summary of the Current Status of DNA Vaccination for Alzheimer Disease

  2023cites this paper
• A Promising Approach: Magnetic Nanosystems for Alzheimer’s Disease Theranostics

  2023cites this paper
• Distinct tau folds initiate templated seeding and alter the post-translational modification profile

  2023cites this paper
• Review of Alzheimer Disease from Pathology, Diagnosis and APOE Targeted Treatment

  2023cites this paper
• Molecular Mechanism of Tau Misfolding and Aggregation: Insights from Molecular Dynamics Simulation.

  2023cites this paper
• Localization, induction, and cellular effects of tau phosphorylated at threonine 217 1

  2023cites this paper
• Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy

  2022cites this paper
• Periodontitis as a Risk Factor for Alzheimer's Disease: The Experimental Journey So Far, with Hope of Therapy.

  2022cites this paper
• Trimethylamine N-oxide: role in cell senescence and age-related diseases

  2022cites this paper
• Localization, induction, and cellular effects of tau-phospho-threonine 217

  2022cites this paper
• Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets

  2022cites this paper
• Toluidine blue O attenuates tau phosphorylation in N2a-APPSwe cells.

  2022cites this paper
• Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities.

  2022cites this paper
• iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU Expression

  2021cites this paper
• Identification of the three zinc-binding sites on Tau protein

  2021cites this paper
• Regulation | Monoamine Oxidases

  2021cites this paper
• PHARMACOLOGICAL EFFECTS OF ASHWAGANDHA (WITHANIA SOMNIFERA) ON NEURODEGENERATIVE DISEASE(ALZHEIMER’S DISEASE)

  2021cites this paper
• Phospho-Tau and Chromatin Landscapes in Early and Late Alzheimer’s Disease

  2021cites this paper
• Different Anesthetic Drugs Mediate Changes in Neuroplasticity During Cognitive Impairment in Sleep-Deprived Rats via Different Factors

  2021cites this paper
• Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia

  2021cites this paper
• Nasal Extracts from Patients with Alzheimer’s Disease Induce Tau Aggregates in a Cellular Model of Tau Propagation

  2021cites this paper
• Review of the Pathology, Diagnosis and Treatment for Alzheimer's Disease

  2021cites this paper
• Astrocyte Senescence and Alzheimer’s Disease: A Review

  2020cites this paper
• Adult Hippocampal Neurogenesis in Major Depressive Disorder and Alzheimer's Disease.

  2020cites this paper
• Meridianins and Lignarenone B as Potential GSK3β Inhibitors and Inductors of Structural Neuronal Plasticity

  2020cites this paper
• Parkinson's Disease: A Comprehensive Analysis of Fungi and Bacteria in Brain Tissue

  2020cites this paper
• Porphyromonas gingivalis is a Strong Risk Factor for Alzheimer’s Disease

  2020cites this paper
• Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?

  2020cites this paper
• RT-QuIC detection of tauopathies using full-length tau substrates

  2020cites this paper
• Stem Cell Therapy for Alzheimer's Disease.

  2020cites this paper
• Nanomedicine against Alzheimer's and Parkinson's disease.

  2020cites this paper
• Development of a brain-permeable peptide nanofiber that prevents aggregation of Alzheimer pathogenic proteins

  2020cites this paper
• Disclosing the Mechanism of Spontaneous Aggregation and Template-Induced Misfolding of the Key Hexapeptide (PHF6) of Tau Protein Based on Molecular Dynamics Simulation.

  2019cites this paper
• Curcumin Offers Potential Efficacy for Treating Alzheimer’s Disease

  2019cites this paper
• Therapeutic approaches to Alzheimer's type of dementia: A focus on FGF21 mediated neuroprotection.

  2019cites this paper
• Epigenetic Mechanisms in Neural Plasticity

  2019cites this paper
• A Snapshot on the Current Status of Alzheimer's Disease, Treatment Perspectives, In-Vitro and In-Vivo Research Studies and Future Opportunities.

  2019cites this paper
• Zinc and Neurodegenerative Disorders

  2019cites this paper
• Effect of temperature, age and lifespan extending interventions on Caenorhabditis elegans models of amyloid beta pathology

  2019cites this paper
• Zinc Induces Temperature-Dependent Reversible Self-Assembly of Tau.

  2019cites this paper
• Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.

  2019cites this paper
• Characterization of microglial Rab7 knockout on amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease

  2019cites this paper
• Aaron Klug and the study of Alzheimer's disease

  2019cites this paper
• The application of patient-derived induced pluripotent stem cells for modeling and treatment of Alzheimer’s disease

  2019cites this paper
• Tau-Cofactor Complexes as Building Blocks of Tau Fibrils

  2019cites this paper
• Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

  2019cites this paper
• Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau

  2018cites this paper
• Thyroid Hormone Enhances Neurite Outgrowth in Neuroscreen 1 Cells

  2018influential citation
• Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation

  2018cites this paper
• Geriatric Diagnostic Imaging

  2018cites this paper
• The relevance of natural compounds in the Alzheimer´s Disease

  2018cites this paper
• Probiotics for Preventing Cognitive Impairment in Alzheimer’s Disease

  2018cites this paper
• Altered Regulation of KIAA0566, and Katanin Signaling Expression in the Locus Coeruleus With Neurofibrillary Tangle Pathology

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer’s Disease Research?

  2018cites this paper
• Alzheimer’s Disease: Adult-Onset of Inborn Error of Methionine Metabolism

  2018cites this paper
• Soluble A&bgr;1‐42 suppresses TNF‐&agr; and activates NLRP3 inflammasome in THP‐1 macrophages

  2018cites this paper
• Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment

  2018cites this paper
• Epitope determines efficacy of therapeutic anti-Tau antibodies in a functional assay with human Alzheimer Tau

  2018cites this paper
• Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches.

  2017cites this paper
• Molecular Pathogenesis of Alzheimer's Disease: An Update

  2017cites this paper
• Stem Cells in Alzheimer’s Disease Therapy

  2017cites this paper
• Immunological memory to hyperphosphorylated tau in asymptomatic individuals

  2017cites this paper
• Conformation-based assay of tau protein aggregation.

  2017cites this paper
• Targeting of Heat Shock Protein HSPA6 (HSP70B′) to the Periphery of Nuclear Speckles is Disrupted by a Transcription Inhibitor Following Thermal Stress in Human Neuronal Cells

  2017cites this paper
• Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

  2017cites this paper
• Personalized Medicine and Resurrected Hopes for the Management of Alzheimer's Disease: A Modular Approach Based on GSK-3β Inhibitors.

  2017cites this paper
• miRNAs in Alzheimer Disease - A Therapeutic Perspective.

  2017cites this paper
• Pathology of Neurodegenerative Diseases.

  2017cites this paper
• Visual Scanning and Attentional Biases in Alzheimerâ s Disease: Assessing Symptoms and Outcomes

  2017cites this paper
• Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain

  2017cites this paper
• Aaron Klug - A Long Way from Durban: A Biography

  2017cites this paper
• Amyloid-beta Causes Autophagy Dysfunction by Inhibiting Protein Prenylation

  2016cites this paper
• Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

  2016influential citation
• Curcumin and Resveratrol in the Management of Cognitive Disorders: What Is the Clinical Evidence?

  2016cites this paper
• The Brain’s Structural Connectome Mediates the Relationship between Regional Neuroimaging Biomarkers in Alzheimer’s Disease

  2016cites this paper
• Precortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology

  2016cites this paper
• Impact of Non-Enzymatic Glycation in Neurodegenerative Diseases: Role of Natural Products in Prevention.

  2016cites this paper
• Brain imaging in dementia

  2016cites this paper
• Review Article Molecular mechanism of prion-like tau-induced neurodegeneration

  2016cites this paper
• Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.

  2016cites this paper
• Searching the Linkage between High Fat Diet and Alzheimerâ²s Disease: A Debatable Proof Stand for Ketogenic Diet to Alleviate Symptoms of Alzheimerâ²s Patient with APOE õ4 Allele

  2016cites this paper
• Exploring the Intertwined Roles of APOE and ABC Genes in the Cognitive Decline of Alzheimers

  2016cites this paper
• Animal Utilization in Drug Development: Clinical, Legal, and Ethical Dimensions

  2016cites this paper
• The role of the prion-like protein SOD1 and macropinocytosis in the propagation of disease in ALS; an infectious idea

  2016cites this paper
• Deciphering the mechanisms underlying the loss of BDNF neuroprotection in an Alzheimer’s disease model

  2016cites this paper
• Développement et caractérisation d'un nouveau modèle expérimental de la maladie d'Alzheimer chez le rat non transgénique

  2016cites this paper
• Molecular Dynamics Simulations of a Powder Model of the Intrinsically Disordered Protein Tau.

  2015cites this paper
• Neuroanatomy and pathology of sporadic Alzheimer's disease.

  2015cites this paper
• Microtubules and the Protein Tau

  2015cites this paper